-
1
-
-
0034649248
-
Congestive heart failure: fifty years of progress
-
Braunwald E., Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 2000, 102:IV14-IV23.
-
(2000)
Circulation
, vol.102
-
-
Braunwald, E.1
Bristow, M.R.2
-
2
-
-
84891705530
-
ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
-
Yancy C.W., Jessup M., Bozkurt B., et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2013, 2013:10.
-
(2013)
J Am Coll Cardiol
, vol.2013
, pp. 10
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
-
3
-
-
0026695294
-
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure
-
Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992, 20:248-254.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 248-254
-
-
Packer, M.1
-
5
-
-
0034162004
-
Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling
-
Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 2000, 35:569-582.
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 569-582
-
-
Cohn, J.N.1
Ferrari, R.2
Sharpe, N.3
-
6
-
-
66249144415
-
Old and new biomarkers of heart failure
-
Emdin M., Vittorini S., Passino C., Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail 2009, 11:331-335.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 331-335
-
-
Emdin, M.1
Vittorini, S.2
Passino, C.3
Clerico, A.4
-
7
-
-
84856554908
-
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance
-
Clerico A., Vittorini S., Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med 2011, 49:1949-1954.
-
(2011)
Clin Chem Lab Med
, vol.49
, pp. 1949-1954
-
-
Clerico, A.1
Vittorini, S.2
Passino, C.3
-
8
-
-
79959895425
-
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones
-
Clerico A., Giannoni A., Vittorini S., Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 2011, 301:H12-H20.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
-
-
Clerico, A.1
Giannoni, A.2
Vittorini, S.3
Passino, C.4
-
9
-
-
23444453873
-
Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide
-
Prontera C., Storti S., Emdin M., et al. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. Clin Chem 2005, 51:1274-1276.
-
(2005)
Clin Chem
, vol.51
, pp. 1274-1276
-
-
Prontera, C.1
Storti, S.2
Emdin, M.3
-
10
-
-
43449109489
-
Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure
-
Hammerer-Lercher A., Halfinger B., Sarg B., et al. Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 2008, 54:858-865.
-
(2008)
Clin Chem
, vol.54
, pp. 858-865
-
-
Hammerer-Lercher, A.1
Halfinger, B.2
Sarg, B.3
-
11
-
-
33646916875
-
Assay for measurement of intact B-type natriuretic peptide prohormone in blood
-
Giuliani I., Rieunier F., Larue C., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006, 52:1054-1061.
-
(2006)
Clin Chem
, vol.52
, pp. 1054-1061
-
-
Giuliani, I.1
Rieunier, F.2
Larue, C.3
-
12
-
-
34250850288
-
Natriuretic peptides: update on peptide release, bioactivity, and clinical use
-
Richards A.M. Natriuretic peptides: update on peptide release, bioactivity, and clinical use. Hypertension 2007, 50:25-30.
-
(2007)
Hypertension
, vol.50
, pp. 25-30
-
-
Richards, A.M.1
-
14
-
-
84862578799
-
Galectins testing: new promises for the diagnosis and risk stratification of chronic diseases?
-
Gruson D., Ko G. Galectins testing: new promises for the diagnosis and risk stratification of chronic diseases?. Clin Biochem 2012, 45:719-726.
-
(2012)
Clin Biochem
, vol.45
, pp. 719-726
-
-
Gruson, D.1
Ko, G.2
-
15
-
-
0032557645
-
X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution
-
Seetharaman J., Kanigsberg A., Slaaby R., Leffler H., Barondes S.H., Rini J.M. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J Biol Chem 1998, 273:13047-13052.
-
(1998)
J Biol Chem
, vol.273
, pp. 13047-13052
-
-
Seetharaman, J.1
Kanigsberg, A.2
Slaaby, R.3
Leffler, H.4
Barondes, S.H.5
Rini, J.M.6
-
16
-
-
0032875554
-
God must love galectins; he made so many of them
-
Cooper D.N., Barondes S.H. God must love galectins; he made so many of them. Glycobiology 1999, 9:979-984.
-
(1999)
Glycobiology
, vol.9
, pp. 979-984
-
-
Cooper, D.N.1
Barondes, S.H.2
-
17
-
-
70349975735
-
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
-
Lin Y.H., Lin L.Y., Wu Y.W., et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta 2009, 409:96-99.
-
(2009)
Clin Chim Acta
, vol.409
, pp. 96-99
-
-
Lin, Y.H.1
Lin, L.Y.2
Wu, Y.W.3
-
18
-
-
69249134131
-
Galectin-3: a novel mediator of heart failure development and progression
-
de Boer R.A., Voors A.A., Muntendam P., van Gilst W.H., van Veldhuisen D.J. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 2009, 11:811-817.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 811-817
-
-
de Boer, R.A.1
Voors, A.A.2
Muntendam, P.3
van Gilst, W.H.4
van Veldhuisen, D.J.5
-
19
-
-
77954658143
-
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
-
Lok D.J., Van Der Meer P., de la Porte P.W., et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 2010, 99:323-328.
-
(2010)
Clin Res Cardiol
, vol.99
, pp. 323-328
-
-
Lok, D.J.1
Van Der Meer, P.2
de la Porte, P.W.3
-
20
-
-
77955463871
-
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
-
Shah R.V., Chen-Tournoux A.A., Picard M.H., van Kimmenade R.R., Januzzi J.L. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail 2010, 12:826-832.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 826-832
-
-
Shah, R.V.1
Chen-Tournoux, A.A.2
Picard, M.H.3
van Kimmenade, R.R.4
Januzzi, J.L.5
-
21
-
-
33748415221
-
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
-
van Kimmenade R.R., Januzzi J.L., Ellinor P.T., et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 2006, %19;48:1217-1224.
-
(2006)
J Am Coll Cardiol
, pp. 1217-1224
-
-
van Kimmenade, R.R.1
Januzzi, J.L.2
Ellinor, P.T.3
-
22
-
-
77951206972
-
Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure
-
Christenson R.H., Duh S.H., Wu A.H., et al. Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure. Clin Biochem 2010, 43:683-690.
-
(2010)
Clin Biochem
, vol.43
, pp. 683-690
-
-
Christenson, R.H.1
Duh, S.H.2
Wu, A.H.3
-
23
-
-
84871809516
-
Performance characteristics of the ARCHITECT galectin-3 assay
-
La'ulu S.L., Apple F.S., Murakami M.M., Ler R., Roberts W.L., Straseski J.A. Performance characteristics of the ARCHITECT galectin-3 assay. Clin Biochem 2013, 46:119-122.
-
(2013)
Clin Biochem
, vol.46
, pp. 119-122
-
-
La'ulu, S.L.1
Apple, F.S.2
Murakami, M.M.3
Ler, R.4
Roberts, W.L.5
Straseski, J.A.6
-
24
-
-
69849105338
-
Analytical assay characterization for 1-108 pro-B-type natriuretic peptide on the BioPlex 2200 analyzer
-
Wu A.H., Smith A., Rame E., et al. Analytical assay characterization for 1-108 pro-B-type natriuretic peptide on the BioPlex 2200 analyzer. Clin Chim Acta 2009, 408:143-144.
-
(2009)
Clin Chim Acta
, vol.408
, pp. 143-144
-
-
Wu, A.H.1
Smith, A.2
Rame, E.3
-
25
-
-
78651387589
-
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
-
de Boer R.A., Lok D.J., Jaarsma T., et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 2011, 43:60-68.
-
(2011)
Ann Med
, vol.43
, pp. 60-68
-
-
de Boer, R.A.1
Lok, D.J.2
Jaarsma, T.3
-
26
-
-
84873744435
-
Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure
-
Gruson D., Lepoutre T., Ahn S.A., Ketelslegers J.M., Rousseau M.F. Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure. Clin Biochem 2013, 46:391-394.
-
(2013)
Clin Biochem
, vol.46
, pp. 391-394
-
-
Gruson, D.1
Lepoutre, T.2
Ahn, S.A.3
Ketelslegers, J.M.4
Rousseau, M.F.5
-
27
-
-
79953887825
-
Galectin-3-independent prognosis in heart failure
-
Carrasco Sanchez F.J. Galectin-3-independent prognosis in heart failure. Clin Res Cardiol 2011, 100:183.
-
(2011)
Clin Res Cardiol
, vol.100
, pp. 183
-
-
Carrasco Sanchez, F.J.1
|